Essential Partners’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2K Buy
535
+162
+43% +$3.71K 0.01% 1134
2026
Q1
$8.69K Hold
373
– – ﹤0.01% 1325
2025
Q4
$7.46K Sell
373
-1,093
-75% -$21.3K ﹤0.01% 1269
2025
Q3
$26.8K Buy
+1,466
New +$28.6K 0.01% 798

Other funds holding INVA

Essential Partners's INVA Position: Q2 2026 in Review

Essential Partners increased its Innoviva (INVA) stake by 43% in Q2 2026, buying an estimated $3.71K and bringing the position to 535 shares worth $12.2K. The position accounts for 0.01% of the portfolio, ranked #1134.

Essential Partners first reported a position in INVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $26.8K in Q3 2025. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Essential Partners held 535 shares of Innoviva worth $12.2K as of Q2 2026.
  • Essential Partners bought 162 Innoviva shares in Q2 2026, an estimated $3.71K.
  • Innoviva made up 0.01% of Essential Partners's portfolio in Q2 2026, its #1134 holding.
  • Essential Partners first reported a position in Innoviva in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Innoviva position peaked at $26.8K in Q3 2025.
  • 309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.